SCHEMBL3277134

SCHEMBL3277134

Cc1cccc2c1cc(C(=O)O)n2Cc1cccc2ccccc12

nearest known ligand 0.57

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
F10 P00742 7/20 0.57
CCR2 P41597 7/20 0.52
CMA1 P23946 1/20 0.50
MCL1 Q07820 2/20 0.49
BAD Q92934 1/20 0.49
FDPS P14324 1/20 0.48
F2 P00734 2/20 0.46
PIK3C2B O00750 1/20 0.45
KDM4E B2RXH2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3283184 0.86 CCR2 (0.60) F10CCR2CMA1MCL1FDPS
SCHEMBL3276218 0.86 FDPS (0.56) F10CCR2CMA1MCL1BAD
SCHEMBL3277800 0.84 CCR2 (0.61) F10CCR2CMA1MCL1BAD
SCHEMBL3276445 0.84 CCR2 (0.55) CCR2CMA1MCL1BADFDPS
SCHEMBL3276828 0.84 CCR9 (0.56) CCR2CMA1MCL1BADFDPS
SCHEMBL3276271 0.81 CCR2 (0.58) CCR2CMA1MCL1BADFDPS
SCHEMBL3276145 0.81 FDPS (0.47) F10CCR2CMA1MCL1BAD
SCHEMBL3283677 0.81 CCR2 (0.60) CCR2MCL1
SCHEMBL3276588 0.80 CCR2 (0.53) F10CCR2CMA1MCL1FDPS
SCHEMBL3283142 0.79 CCR2 (0.61) CCR2MCL1FDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7696240-B2 Fused pyrrole derivatives HOFFMANN-LA ROCHE INC. (US) 2010-04-13 US claimed
EP-1966134-B1 NOVEL FUSED PYRROLE DERIVATIVES HOFFMANN LA ROCHE (CH) 2014-03-12 EP disclosed
EP-1966134-B1 NOVEL FUSED PYRROLE DERIVATIVES HOFFMANN LA ROCHE (CH) 2014-03-12 EP disclosed
US-7696240-B2 Fused pyrrole derivatives HOFFMANN-LA ROCHE INC. (US) 2010-04-13 US disclosed
US-7696240-B2 Fused pyrrole derivatives HOFFMANN-LA ROCHE INC. (US) 2010-04-13 US disclosed
US-7696240-B2 Fused pyrrole derivatives HOFFMANN-LA ROCHE INC. (US) 2010-04-13 US disclosed
EP-1966134-A1 NOVEL FUSED PYRROLE DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2008-09-10 EP disclosed
WO-2007068621-A1 NOVEL FUSED PYRROLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-06-21 WO disclosed
WO-2007068621-A1 NOVEL FUSED PYRROLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-06-21 WO disclosed
US-20070142452-A1 Fused pyrrole derivatives HOFFMANN-LA ROCHE INC. 2007-06-21 US disclosed
US-20070142452-A1 Fused pyrrole derivatives HOFFMANN-LA ROCHE INC. 2007-06-21 US disclosed
US-20070142452-A1 Fused pyrrole derivatives HOFFMANN-LA ROCHE INC. 2007-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142452-A1 Fused pyrrole derivatives CMA1, PREP, CPA3 F10 881/4885CCR2 2308/4885CMA1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.